1st Circ. Partially Resurrects Azurity's Beef With Edge Pharma
The First Circuit on Friday partially revived portions of Azurity Pharmaceuticals' suit against Edge Pharma over its competing hydrochloride vancomycin drug, agreeing with a Massachusetts federal court that some of its claims don't hold up, but not for the same reason.
Source: law360.com